Phase I/Ib Trial of ATR Inhibitor BAY 1895344 in Combination With FOLFIRI in GI Malignancies With a Focus on Metastatic Colorectal and Gastric/Gastroesophageal Cancers
Latest Information Update: 12 Oct 2024
At a glance
- Drugs Elimusertib (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer; Gastric cancer; Gastrointestinal cancer; Oesophageal cancer
- Focus Adverse reactions
- 30 Apr 2024 Planned End Date changed from 31 Dec 2024 to 29 Apr 2025.
- 23 Dec 2023 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 23 Dec 2023 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.